Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0122 | 0.4015 | 0.5 |
Plasmodium vivax | thymidylate kinase, putative | 0.0122 | 0.4015 | 0.5 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.0122 | 0.4015 | 0.5 |
Schistosoma mansoni | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Echinococcus multilocularis | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Loa Loa (eye worm) | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Giardia lamblia | CDC8 | 0.0122 | 0.4015 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0122 | 0.4015 | 0.5 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0122 | 0.4015 | 0.5 |
Leishmania major | thymidylate kinase-like protein | 0.0122 | 0.4015 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0122 | 0.4015 | 0.5 |
Schistosoma mansoni | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Mycobacterium ulcerans | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | 0.0122 | 0.4015 | 0.5 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0122 | 0.4015 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0122 | 0.4015 | 0.5 |
Chlamydia trachomatis | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0122 | 0.4015 | 0.5 |
Mycobacterium leprae | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) | 0.0122 | 0.4015 | 0.5 |
Treponema pallidum | thymidylate kinase (tmk) | 0.0122 | 0.4015 | 0.5 |
Brugia malayi | thymidylate kinase | 0.0122 | 0.4015 | 1 |
Echinococcus granulosus | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Plasmodium falciparum | thymidylate kinase | 0.0122 | 0.4015 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.